Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Da Huang total anthraquinone capsules in chronic hepatitis B jaundice
CTR20140733Phase 4Completed
- Sponsor
- Jiangxi Changnuo Pharmaceutical
- Start
- Nov 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Da Huang total anthraquinone capsule in Chronic Hepatitis B (CHB), jaundice, sponsored by Jiangxi Changnuo Pharmaceutical. Started Nov 2014; status: completed.
02
Drugs
Da Huang total anthraquinone capsule
03
Conditions
Chronic Hepatitis B (CHB)jaundice
Beyond the preview
Go deeper on CTR20140733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140733.